Brief: Abbisko Cayman Says FDA Grants Fast Track Designation To Abbisko's Irpagratinib
10/02/2026 01:26
Feb 10 (Reuters) - Abbisko Cayman 2256.HK: FDA GRANTS FAST TRACK DESIGNATION TO ABBISKO'S IRPAGRATINIB Further company coverage: 2256.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abbisko Cayman
See all newsHK-listed Abbisko climbs most in 12 weeks on Eli Lilly tie-up
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly (updated)
Brief: Abbisko Therapeutics Deepens R+D- Collaboration With Lilly
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly
Brief: Abbisko Therapeutics Enters Strategic Research Collaboration And License Agreement With Eli Lilly